Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
Innventure, an industrial growth conglomerate listed on NASDAQ under ticker INV, announces that Dr. Bill Grieco will succeed Bill Haskell as CEO effective October 1, 2026. The leadership transition follows a comprehensive search and reflects an emphasis on continuity and growth. Dr. Grieco brings strong internal experience and a history of leading …
Monopar Therapeutics announced that the FDA has granted Rare Pediatric Disease designation to its late-stage drug candidate ALXN1840 for treating Wilson disease, a rare genetic disorder causing toxic copper accumulation. This designation could lead to priority review vouchers, accelerating future drug approvals or providing financial benefits. ALXN…
Sharplink, Inc., a Nasdaq-listed company focused on Ethereum treasury management, announced the purchase of 10,000 ETH, increasing total ETH holdings to 886,725, alongside repurchasing over 2.1 million shares as part of its ongoing stock buyback program. The company also raised $75 million through a direct offering to support its ETH accumulation s…
Kaltura has been recognized by Gartner in its 2026 Market Guide for Meeting Solutions, highlighting its strength as an enterprise-grade platform for virtual meetings, classrooms, and digital experiences. The company's agentic AI-driven meeting tools enable real-time, personalized engagement and content delivery, enhancing communication and knowledg…
Biodexa Pharmaceuticals PLC announced the pricing of a $3.5 million funding package, including a registered direct offering and concurrent private placement of pre-funded warrants and warrants. The proceeds will support ongoing clinical development of its biopharmaceutical pipeline targeting diseases with unmet medical needs, including cancer and d…
Allarity Therapeutics announced the granting of a key U.S. patent by the USPTO for its stenoparib-specific Drug Response Predictor (DRP®) companion diagnostic, providing exclusivity for the combined use of stenoparib with the DRP® until April 2042. This intellectual property milestone supports the company's strategy for advancing precision medicine…
Aduro Clean Technologies announced a Memorandum of Understanding with AstroTurf to evaluate the use of Aduro's Hydrochemolytic™ Technology in recycling polyethylene and polypropylene components of synthetic turf. The collaboration aims to develop a technical and economic pathway for recovering valuable plastics from end-of-life synthetic turf, supp…
Genius Group Limited disclosed that its investors have initiated a class action lawsuit against Citadel Securities LLC and Virtu Americas LLC for alleged long-running market manipulation involving spoofing and naked short selling of Genius Group shares. The company reports over $250 million in damages due to these actions and plans to join the laws…
VisionWave Holdings, a U.S. defense technology company, announced a definitive agreement to acquire a 51% controlling stake in Meteor Aerospace Ltd., an Israeli aerospace and defense company known for advanced unmanned systems and integrated national security technologies. The acquisition, subject to customary closing conditions including flight va…
MediciNova, a clinical-stage biopharmaceutical company, reports significant progress including completion of the last patient visit in its Phase 2 trial for MN-001 targeting NAFLD associated with type 2 diabetes, advances in the Phase 3 ALS trial with MN-166, and receipt of a U.S. patent allowance for combination therapy in glioblastoma. The compan…
Leonardo DRS, Inc., a defense technology company, announced it will hold a conference call on July 30, 2026, to discuss its second quarter 2026 financial results. The earnings press release and supplemental information will be available on the investor relations website. The company specializes in advanced defense solutions for U.S. national securi…
SCYNEXIS, Inc. has initiated a Phase 1 clinical study for SCY-770, a novel and potent oral AMPK activator aimed at treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The study will evaluate food effects and pharmacokinetics to support dose selection for a Phase 2 proof-of-concept trial expected to begin in Q4 2026. SCY-770 has shown pro…
Akebia Therapeutics and U.S. Renal Care announced the early termination of the VOICE trial after interim analysis demonstrated Vafseo (vadadustat), administered three times weekly, provided statistically significant and clinically meaningful safety benefits for patients with anemia due to chronic kidney disease on dialysis compared to erythropoiesi…
Lands' End announced the appointment of Charlie Cole as CEO, succeeding Andrew McLean, who will transition to an advisory role. Cole brings extensive experience in consumer brands, digital transformation, and AI, aiming to build upon recent strategic progress and drive future growth. The company highlighted a $100 million share repurchase program r…
Teamshares Inc., a tech-enabled acquiror of small and medium-sized enterprises (SMEs), will present at the 26th Annual CJS New Ideas Summer Conference on July 9, 2026. The presentation will be led by CFO Brian Gaebe and Head of Capital Markets Nile Corso. The company focuses on acquiring SMEs from retiring owners and integrating them into its platf…
Enphase Energy has joined the Open Compute Project as a Platinum member to help develop open standards for next-generation AI data center power infrastructure, including advanced high-voltage DC power architectures. Leveraging its two decades of distributed power electronics experience and its newly developed IQ Solid-State Transformer technology, …
LB Pharmaceuticals appoints Christopher Zergebel as Senior Vice President, Clinical Operations, to lead execution of clinical programs for LB-102, a novel neuropsychiatric drug candidate. Active Phase 3 and Phase 2 trials for schizophrenia, bipolar depression, and major depressive disorder signal strategic advancement in their pipeline.
Atlantic International Corp., trading on Nasdaq under ticker ATLN, announces a corporate name change to Circle8 Group, Inc. with a new ticker symbol CIRC, reflecting its evolution into a global technology and workforce solutions platform with over $1.2 billion annualized revenue. The company appoints Guus Franke as CEO, emphasizing an integrated pl…
Design Therapeutics has begun dosing patients in its Phase 1 multiple ascending dose clinical trial evaluating DT-818, a GeneTAC® small molecule aimed at selectively reducing transcription of the mutant DMPK allele, addressing the underlying cause of myotonic dystrophy type-1 (DM1). This trial marks a key milestone in developing a potential best-in…
ALX Oncology announced key leadership changes, appointing Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel. Garland succeeds co-founder Corey Goodman, who steps down after over a decade of leadership. These appointments aim to support the company's strategic growth and advancement of its oncology drug pipeline, inclu…
Eos Energy Enterprises announced a $75 million equity investment from Hudson Bay Capital Management plus a $50 million direct investment into Frontier Power USA, raising FPUSA's expected equity investment to $375 million. This capital base is projected to support $1.5 billion in project deployment for long-duration zinc-based energy storage solutio…
Eos Energy Enterprises announced updated terms for a rights offering to its common stock and warrant holders. The offering allows eligible holders to purchase units consisting of common stock and warrants at a 10% discount, to fund the company’s capital contribution to the Frontier Power USA joint venture. The rights offering will be conducted unde…
ZenaTech, a Nasdaq-listed technology company specializing in AI-powered drone platforms and Drone as a Service (DaaS), reported an annualized revenue run rate of approximately CAD $33 million based on its Q1 2026 revenue figures. The company attributes growth to its acquisition strategy, integrating under-digitized service businesses and expanding …
Eos Energy Enterprises announced a registered direct offering with Hudson Bay Capital Management raising approximately $75 million through common stock and warrants to fund its contribution to Frontier Power USA Parent, LLC (FPUSA). The financing supports FPUSA’s robust pipeline of 16 GWh long-duration energy storage projects across the U.S., enabl…
Pyxis Oncology has entered a private placement financing agreement to raise approximately $50 million upfront, with potential additional proceeds of $64 million if warrants are exercised. The funding will extend the company's cash runway into Q2 2027 and support advancement of their lead candidate, MICVO, through key clinical milestones in head and…
